Health Care Industry News
Merck's Erbitux receives EC approval for head & neck cancer
Pharmabiz.com (India) | 5 minutes ago
Merck KGaA and its Merck Serono division announced that it has received approval from the European Commission to extend the use of its targeted therapy Erbitux (cetuximab) to include first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN). Erbitux was previously approved for use in combination with radiotherapy for locally advanced disease.... (more)
Latest Health Care Industry NewsMore >
US FDA grants priority review status for Cell Therapeutics' Zevalin
Pharmabiz.com (India) | 5 minutes ago
Johnson & Johnson to acquire Mentor Corporation for $1.07 bn
Pharmabiz.com (India) | 5 minutes ago
Bilcare expands clinical supplies facility in India
Pharmabiz.com (India) | 5 minutes ago
US FDA accepts Biovail's ANDA for quetiapine fumarate tabs
Pharmabiz.com (India) | 6 minutes ago
Readers ChoiceMore >
Officials, groups call for extensive reforms at FDA
FDLI SmartBrief | Nov 26, 2008
Concerns arise about studies conducted overseas
FDLI SmartBrief | Dec 02, 2008
FDA staff: Solvay's enzyme pill has pig-virus risks
FDLI SmartBrief | Dec 01, 2008
FDA might be poised to OK stevia-based sweeteners
FDLI SmartBrief | Dec 02, 2008
FDA outlines "hugely ambitious" food-inspection campaign
FDLI SmartBrief | Dec 01, 2008
FDLI News
More >
A Human Resource Recruitment Tool
FDLI SmartBrief | Dec 03, 2008
What can the food industry expect from FDA during the new administration?
FDLI SmartBrief | Dec 03, 2008
Last chance to register and appear on the attendee list! "The Regulation of Controlled Substances and Diversion Control" conference, Dec. 4 and 5; Receive CLEs
FDLI SmartBrief | Dec 02, 2008
Call for Sessions: FDLI's 52nd Annual Conference, April 22 and 23, 2009
FDLI SmartBrief | Dec 02, 2008
This week! Risks, Roles & Responsibilities in "The Regulation of Controlled Substances and Diversion Control" conference, Dec. 4 and 5; CLEs approved! Register today!
FDLI SmartBrief | Dec 01, 2008
Latest Health Care Industry Press ReleasesMore >
Pregnant women with asthma can be more confident about some medicines
EurekAlert! | 6 hours 49 minutes ago
Flu Vaccine Linked To Reduced Illness, Impairment Of Academic Performance Among College Students
Science Daily Magazine | 1 day 7 hours 40 minutes ago
Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
PRNewswire | 2 days 6 hours 45 minutes ago
PAREXEL International to Present at NASDAQ OMX 22nd Investor Program
PRNewswire | 2 days 6 hours 45 minutes ago
SILENCE THERAPEUTICS PLC - Research Update
PRNewswire | 2 days 6 hours 46 minutes ago
Sign up for FDLI SmartBrief
Latest Blog Postsview more
Genes determine whether placebos work
Science Blog
How to Destroy an Asteroid
Science Blog
Cleveland Clinic Has Something to Tell Us
Medical Device & Diagnostic Industry/DeviceTalk
ZackBorg with EyeSeeCam
Corante/Brain Waves
Job Listingsview more
- Associate General Counsel - Regulatory
Cardinal Health - Corporate Counsel
Genentech - Director, Compliance
Salix Pharmaceuticals
Companies in the news
- Aetna Incorporated
- Alpharma Inc
- Antigenics Inc
- AstraZeneca PLC
- Biogen IDEC Inc.
- Cell Therapeutics Inc
- Genentech
- Harvard Pilgrim Health Care
- Health Care
- Johnson & Johnson
- King Pharmaceuticals Inc
- Mentor Corp
- Merck & Co Inc
- Protherics PLC
- UnitedHealth Group Inc.
Recent Poll view more polls